Alpha Cognition Inc
NASDAQ: ACOG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- CEO
- Michael E. McFadden
- Employees
- 71
- Headquarters
- Grapevine, United States
- IPO year
- 2024
- Market cap
- $102.2M
- Website
- https://www.alphacognition.com
Loading ACOG…
Loading profile data…Frequently asked questions about ACOG
What does Alpha Cognition Inc (ACOG) do?
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise...
Where does ACOG trade?
Alpha Cognition Inc (ACOG) trades on the NASDAQ.
What sector is ACOG in?
Alpha Cognition Inc (ACOG) operates in the Financial Services sector, specifically in the Financial - Conglomerates industry.
Who is the CEO of Alpha Cognition Inc?
Michael E. McFadden is the chief executive officer of Alpha Cognition Inc (ACOG).
Where is Alpha Cognition Inc headquartered?
Alpha Cognition Inc is headquartered in United States.
Does ACOG pay a dividend?
Alpha Cognition Inc (ACOG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACOG go public?
Alpha Cognition Inc (ACOG) completed its initial public offering in 2024.